ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00842491
Recruitment Status : Completed
First Posted : February 12, 2009
Last Update Posted : May 19, 2015
Sponsor:
Collaborator:
Xiansheng Pharmaceutical Company
Information provided by (Responsible Party):
Shen Lin, Peking University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2010
  Actual Study Completion Date : December 2010